임상의사결정지원시스템 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)
Global Clinical Decision Support System Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
상품코드:1683302
리서치사:Value Market Research
발행일:2025년 03월
페이지 정보:영문 159 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
임상의사결정지원시스템 세계 시장 규모는 2024년 33억 1,000만 달러에서 2033년 92억 8,000만 달러로 2026년부터 2033년까지 예측 기간 동안 12.14%의 견고한 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
세계 임상의사결정지원시스템(CDSS) 시장은 의료 결과 개선과 효율적인 임상 워크플로우에 대한 수요 증가에 힘입어 크게 성장할 것으로 예상되며, CDSS 도구는 환자 치료 중 근거에 기반한 권장사항, 경고 및 알림을 제공하여 의료 전문가가 정보에 입각한 의사결정을 내릴 수 있도록 지원합니다. 의료 전문가가 정보에 입각한 의사결정을 내릴 수 있도록 지원합니다. 의료 서비스 제공자가 환자 안전을 높이고, 실수를 줄이고, 치료 계획을 최적화하기 위해 노력함에 따라 CDSS의 채택이 크게 증가하여 이 중요한 시장에 대한 혁신과 투자를 촉진할 것으로 예상됩니다.
또한, 인공지능(AI)과 머신러닝의 발전은 CDSS의 전망을 바꾸어 놓을 것입니다. 이러한 기술의 통합은 보다 정교한 데이터 분석을 가능하게 하여 CDSS가 개별 환자 데이터와 임상 가이드라인에 기반한 개인화된 추천을 제공할 수 있게 해줍니다. 또한, 가치 기반 의료와 집단건강관리에 대한 관심이 높아지면서 대규모 데이터세트를 분석하여 추세를 파악하고 환자 결과를 개선할 수 있는 CDSS 솔루션에 대한 수요가 증가하고 있습니다. 헬스케어 산업이 계속 발전함에 따라 임상의사결정지원시스템 시장은 임상적 의사결정을 강화하고 의료 서비스 전반을 개선하는 혁신적인 솔루션에 대한 수요가 급증할 것으로 보입니다.
또한, 규제 준수와 상호운용성에 대한 관심이 높아지면서 CDSS 시장의 미래를 좌우할 것으로 예상됩니다. 정부 및 의료 기관이 데이터 보안 및 환자 프라이버시 규제를 강화함에 따라, 이러한 표준을 준수하는 CDSS 솔루션에 대한 수요는 계속 증가할 것으로 보입니다. 기술 제공업체, 의료 기관, 규제 당국의 협력은 임상의사결정지원시스템 시장이 의료 제공자와 환자의 진화하는 요구에 계속 대응할 수 있도록 보장하고 이러한 발전을 촉진하는 데 필수적일 것입니다.
당사의 보고서는 고객에게 다양한 산업 및 시장에 대한 포괄적이고 실용적인 인사이트를 제공하기 위해 세심하게 작성되었습니다. 각 보고서는 시장 상황을 완전히 이해하기 위해 몇 가지 중요한 요소를 포함하고 있습니다:
시장 개요 : 정의, 분류, 산업 현황 등 시장에 대한 자세한 소개.
시장 역학 : 시장 성장에 영향을 미치는 주요 촉진요인, 억제요인, 기회 및 과제를 자세히 분석합니다. 이 섹션에서는 기술 발전, 규제 변화, 새로운 트렌드 등의 요인을 검토합니다.
세분화 분석 : 제품 유형, 용도, 최종사용자, 지역 등의 기준에 따라 시장을 명확한 부문으로 분류합니다. 이 분석을 통해 각 부문의 성과와 잠재력을 파악할 수 있습니다.
경쟁 상황 : 시장 점유율, 제품 포트폴리오, 전략적 이니셔티브, 재무 실적 등 주요 시장 기업의 종합적인 평가. 주요 기업들이 채택하고 있는 경쟁 역학 및 주요 전략에 대한 인사이트를 제공합니다.
시장 예측 : 과거 데이터와 현재 시장 상황을 바탕으로 일정 기간 동안 시장 규모와 성장 추세를 예측합니다. 여기에는 정량적 분석과 향후 시장 궤적을 보여주는 그래프 표시가 포함됩니다.
지역 분석 : 지역별 시장 성과를 평가하고 주요 시장 및 지역 동향을 파악할 수 있습니다. 지역 시장 역학 및 비즈니스 기회를 이해하는 데 도움이 됩니다.
새로운 트렌드와 기회 : 현재 시장 동향과 새로운 시장 동향, 기술 혁신, 잠재적 투자 대상 분야를 파악합니다. 향후 시장 개척 및 성장 전망에 대한 인사이트를 제공합니다.
Global Clinical Decision Support System Market size is anticipated to grow from USD 3.31 Billion in 2024 to USD 9.28 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 12.14% during the forecast period of 2026 to 2033.
The global clinical decision support system (CDSS) market is poised for significant growth, driven by the increasing demand for improved healthcare outcomes and the need for efficient clinical workflows. CDSS tools assist healthcare professionals in making informed decisions by providing evidence-based recommendations, alerts, and reminders during patient care. As healthcare providers strive to enhance patient safety, reduce errors, and optimize treatment plans, the adoption of CDSS is expected to rise substantially, fostering innovation and investment in this critical market.
Moreover, advancements in artificial intelligence (AI) and machine learning are set to transform the CDSS landscape. The integration of these technologies allows for more sophisticated data analysis, enabling CDSS to provide personalized recommendations based on individual patient data and clinical guidelines. Additionally, the growing emphasis on value-based care and population health management is driving the demand for CDSS solutions that can analyze large datasets to identify trends and improve patient outcomes. As the healthcare industry continues to evolve, the market for clinical decision support systems is likely to witness a surge in demand for innovative solutions that enhance clinical decision-making and improve overall healthcare delivery.
In addition, the increasing focus on regulatory compliance and interoperability is expected to shape the future of the CDSS market. As governments and healthcare organizations implement stricter regulations regarding data security and patient privacy, the demand for CDSS solutions that comply with these standards will continue to rise. Collaborative efforts between technology providers, healthcare institutions, and regulatory bodies will be essential in driving these advancements, ensuring that the clinical decision support system market remains responsive to the evolving needs of healthcare providers and patients.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
SEGMENTATION COVERED IN THE REPORT
By Component
Software
Hardware
Services
By Delivery Mode
On-Premise
Cloud-Based
By Application
Drug Databases
Care Plans
Diagnostic Decision Support
Disease Reference
Others
By End-User
Hospitals
Clinics
Ambulatory Surgical Centers
Others
COMPANIES PROFILED
McKesson Corporation
Siemens Healthineers
IBM Watson Health
Hearst Health
Cerner Corporation
Wolters Kluwer Health
Philips Healthcare
Elsevier B.V.
Veradigm Inc. (formerly Allscripts Healthcare Solutions Inc.)
3. CLINICAL DECISION SUPPORT SYSTEM INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Component
3.7.2 Market Attractiveness Analysis By Delivery Mode
3.7.3 Market Attractiveness Analysis By Application
3.7.4 Market Attractiveness Analysis By End-User
3.7.5 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY COMPONENT
5.1. Overview By Component
5.2. Historical and Forecast Data Analysis By Component
5.3. Software Historic and Forecast Sales By Regions
5.4. Hardware Historic and Forecast Sales By Regions
5.5. Services Historic and Forecast Sales By Regions
6. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY DELIVERY MODE
6.1. Overview By Delivery Mode
6.2. Historical and Forecast Data Analysis By Delivery Mode
6.3. On-Premise Historic and Forecast Sales By Regions
6.4. Cloud-Based Historic and Forecast Sales By Regions
7. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY APPLICATION
7.1. Overview By Application
7.2. Historical and Forecast Data Analysis By Application
7.3. Drug Databases Historic and Forecast Sales By Regions
7.4. Care Plans Historic and Forecast Sales By Regions
7.5. Diagnostic Decision Support Historic and Forecast Sales By Regions
7.6. Disease Reference Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions
8. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY END-USER
8.1. Overview By End-User
8.2. Historical and Forecast Data Analysis By End-User
8.3. Hospitals Historic and Forecast Sales By Regions
8.4. Clinics Historic and Forecast Sales By Regions
8.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions
9. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
9.3.1 Overview, Historic and Forecast Data Sales Analysis
9.3.2 North America By Segment Sales Analysis
9.3.3 North America By Country Sales Analysis
9.3.4 United States Sales Analysis
9.3.5 Canada Sales Analysis
9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
9.4.1 Overview, Historic and Forecast Data Sales Analysis
9.4.2 Europe By Segment Sales Analysis
9.4.3 Europe By Country Sales Analysis
9.4.4 United Kingdom Sales Analysis
9.4.5 France Sales Analysis
9.4.6 Germany Sales Analysis
9.4.7 Italy Sales Analysis
9.4.8 Russia Sales Analysis
9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
9.5.1 Overview, Historic and Forecast Data Sales Analysis
9.5.2 Asia Pacific By Segment Sales Analysis
9.5.3 Asia Pacific By Country Sales Analysis
9.5.4 China Sales Analysis
9.5.5 India Sales Analysis
9.5.6 Japan Sales Analysis
9.5.7 South Korea Sales Analysis
9.5.8 Australia Sales Analysis
9.5.9 South East Asia Sales Analysis
9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
9.6.1 Overview, Historic and Forecast Data Sales Analysis
9.6.2 Latin America By Segment Sales Analysis
9.6.3 Latin America By Country Sales Analysis
9.6.4 Brazil Sales Analysis
9.6.5 Argentina Sales Analysis
9.6.6 Peru Sales Analysis
9.6.7 Chile Sales Analysis
9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
9.7.1 Overview, Historic and Forecast Data Sales Analysis
9.7.2 Middle East & Africa By Segment Sales Analysis
9.7.3 Middle East & Africa By Country Sales Analysis
9.7.4 Saudi Arabia Sales Analysis
9.7.5 UAE Sales Analysis
9.7.6 Israel Sales Analysis
9.7.7 South Africa Sales Analysis
9.7.8 Rest Of Middle East And Africa Sales Analysis
10. COMPETITIVE LANDSCAPE OF THE CLINICAL DECISION SUPPORT SYSTEM COMPANIES
10.1. Clinical Decision Support System Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11. COMPANY PROFILES OF CLINICAL DECISION SUPPORT SYSTEM INDUSTRY
11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. McKesson Corporation
11.3.1 Company Overview
11.3.2 Company Revenue
11.3.3 Products
11.3.4 Recent Developments
11.4. Siemens Healthineers
11.4.1 Company Overview
11.4.2 Company Revenue
11.4.3 Products
11.4.4 Recent Developments
11.5. IBM Watson Health
11.5.1 Company Overview
11.5.2 Company Revenue
11.5.3 Products
11.5.4 Recent Developments
11.6. Hearst Health
11.6.1 Company Overview
11.6.2 Company Revenue
11.6.3 Products
11.6.4 Recent Developments
11.7. Cerner Corporation
11.7.1 Company Overview
11.7.2 Company Revenue
11.7.3 Products
11.7.4 Recent Developments
11.8. Wolters Kluwer Health
11.8.1 Company Overview
11.8.2 Company Revenue
11.8.3 Products
11.8.4 Recent Developments
11.9. Philips Healthcare
11.9.1 Company Overview
11.9.2 Company Revenue
11.9.3 Products
11.9.4 Recent Developments
11.10. Elsevier B.V.
11.10.1 Company Overview
11.10.2 Company Revenue
11.10.3 Products
11.10.4 Recent Developments
11.11. Veradigm Inc. (Formerly Allscripts Healthcare Solutions Inc.)
11.11.1 Company Overview
11.11.2 Company Revenue
11.11.3 Products
11.11.4 Recent Developments
11.12. NextGen Healthcare Information Systems LLC
11.12.1 Company Overview
11.12.2 Company Revenue
11.12.3 Products
11.12.4 Recent Developments
11.13. MEDITECH
11.13.1 Company Overview
11.13.2 Company Revenue
11.13.3 Products
11.13.4 Recent Developments
11.14. GE Healthcare
11.14.1 Company Overview
11.14.2 Company Revenue
11.14.3 Products
11.14.4 Recent Developments
11.15. Change Healthcare
11.15.1 Company Overview
11.15.2 Company Revenue
11.15.3 Products
11.15.4 Recent Developments
11.16. Athenahealth Inc.
11.16.1 Company Overview
11.16.2 Company Revenue
11.16.3 Products
11.16.4 Recent Developments
11.17. Optum Inc
11.17.1 Company Overview
11.17.2 Company Revenue
11.17.3 Products
11.17.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
